Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

STE
STERIS plc
stock NYSE

Market Open
Jun 30, 2026 11:09:31 AM EDT
209.87USD-1.580%(-3.37)149,045
197.89Bid   209.95Ask   12.06Spread
Pre-market
Jun 30, 2026 9:00:30 AM EDT
210.30USD-1.379%(-2.94)100
After-hours
Jun 29, 2026 4:00:30 PM EDT
213.24USD-0.002%(0.00)0
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsDividendsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 31, 2022
04:30PM EST  STERIS plc (NYSE: STE) (STERIS or the Company) announced today that the Company will distribute a quarterly interim dividend of $0.43 per share. The dividend is payable March 24, 2022 to shareholders of record at the close of business on February 25, 2022.   GlobeNewswire Inc
Jan 25, 2022
04:30PM EST  STERIS to Host a Conference Call for Fiscal 2022 Third Quarter   GlobeNewswire Inc
Jan 3, 2022
04:19PM EST  Evoqua Water Technologies Closes Acquisition Of Renal Business From STERIS   RTTNews
Dec 21, 2021
07:01AM EST  OTC Markets Group Welcomes Starr Peak Mining Ltd. to OTCQX   PR Newswire
Dec 20, 2021
07:01AM EST  Evoqua Water Technologies Signs Definitive Agreement To Acquire Renal Business From STERIS For $196.3M   Benzinga
Dec 2, 2021
12:09PM EST  If You Invested $100 Over The Past 5 Years In This Stock, Here's How Much You Would Have Today   Benzinga
Nov 4, 2021
09:22AM EDT  Stephens & Co. Maintains Overweight on Steris, Raises Price Target to $270   Benzinga
04:40AM EDT  Keybanc Maintains Overweight on Steris, Raises Price Target to $256   Benzinga
Nov 2, 2021
05:40PM EDT  Steris Q2 EPS $1.99 Beats $1.82 Estimate, Sales $1.20B Beat $1.15B Estimate   Benzinga
05:14PM EDT  STERIS plc (STE) announced earnings for second quarter that decreased from the same period last year.   RTTNews
05:01PM EDT  STERIS Q2 EPS $0.69 Vs. $1.23 Year Ago   RTTNews
10:41AM EDT  Earnings Scheduled For November 2, 2021   Benzinga
Oct 20, 2021
04:30PM EDT  STERIS to Host a Conference Call for Fiscal 2022 Second Quarter   GlobeNewswire Inc
Aug 11, 2021
10:04AM EDT  A Look Into Steris Price Over Earnings   Benzinga
08:37AM EDT  Baird Maintains Outperform on Steris, Raises Price Target to $250   Benzinga
08:33AM EDT  Stephens & Co. Maintains Overweight on Steris, Raises Price Target to $255   Benzinga
04:41AM EDT  Keybanc Maintains Overweight on Steris, Raises Price Target to $239   Benzinga
Aug 9, 2021
04:35PM EDT  UPDATE: Steris Raises FY22 Sales Guidance From $4.5B To $4.6B vs $4.33B Estimate, Adj. EPS From $7.40-$7.65 To $7.60-$7.85 vs $7.41 Est.   Benzinga
04:33PM EDT  Steris Q1 Adj. EPS $1.76 Beats $1.51 Estimate, Sales $968.40M Beat $881.72M Estimate; Raises Guidance   Benzinga
04:11AM EDT  Earnings Scheduled For August 9, 2021   Benzinga
Jun 2, 2021
09:10AM EDT  STERIS Completes Acquisition Of Cantel Medical   RTTNews
09:00AM EDT  STERIS plc (NYSE: STE) (STERIS or the Company) today announced that it has completed the previously announced acquisition of Cantel Medical, a global provider of infection prevention products and services to endoscopy, dental, dialysis and life sciences Customers.   GlobeNewswire Inc
May 26, 2021
10:09AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For May 26, 2021   Benzinga
06:05AM EDT  Needham Upgrades Steris to Buy, Announces $233 Price Target   Benzinga
May 18, 2021
04:58PM EDT  Recap: Steris Q4 Earnings   Benzinga
04:45PM EDT  Steris Q4 EPS $1.63 May Not Compare To $1.77 Estimate, Sales $873.50M Miss $876.21M Estimate   Benzinga
04:34PM EDT  STERIS Sees FY22 EPS $7.40-$7.65 Vs $7 Estimates   Benzinga
04:32PM EDT  Steris Q4 EPS $1.64 May Not Compare To $1.77 Estimate, Sales $873.50M Miss $876.21M Estimate   Benzinga
04:30PM EDT  -- Fourth quarter revenue increases 6% as reported; full year increases 3% as reported -- Full year earnings per diluted share of $4.63 on a U.S. GAAP basis and $6.17 on an adjusted basis on effective tax rates of 23.3% and 20.7%, respectively -- Company provides outlook for fiscal 2022 includingCantel Medical   GlobeNewswire Inc
04:08AM EDT  Earnings Scheduled For May 18, 2021   Benzinga
May 17, 2021
10:08AM EDT  Preview: Steris's Earnings   Benzinga
May 11, 2021
04:30PM EDT  -- David B. Lewis to retire at the Companys 2021 Annual Meeting of Shareholders -- Company appoints Paul E. Martin to Board   GlobeNewswire Inc
10:46AM EDT  JMP Securities Maintains Market Outperform on Steris, Raises Price Target to $235   Benzinga
Apr 27, 2021
07:17AM EDT  STERIS Expects FY21 Sales ~$3.1B; Sees FY21 Income From Operations Of $548M   Benzinga
07:00AM EDT  -- Company expects to close the Cantel Medical acquisition by June 2, 2021, pending shareholder vote   GlobeNewswire Inc
Mar 11, 2021
05:14AM EST  KeyBanc Maintains Overweight on Steris, Raises Price Target to $227   Benzinga
Mar 9, 2021
07:02AM EST  Cantel Medical Q2 Net Sales $294.0 Mln, Up 1.9% From Last Year   RTTNews
07:01AM EST  Cantel Medical Reports Strong Financial Results for its Second Quarter Fiscal   PR Newswire
Feb 22, 2021
10:13AM EST  Understanding Steris's Ex-Dividend Date   Benzinga
Feb 9, 2021
03:37PM EST  Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cantel Medical Corp - CMD   PR Newswire
Feb 4, 2021
10:03AM EST  Benzinga's Top Ratings Upgrades, Downgrades For February 4, 2021   Benzinga
05:02AM EST  KeyBanc Upgrades Steris to Overweight, Announces $224 Price Target   Benzinga
Feb 3, 2021
07:10AM EST  STERIS Announces Walt Rosebrough To Step Down As CEO; Dan Carestio To Succeed As President And Ceo   Benzinga
07:00AM EST  -- Walt Rosebrough to step down as CEO at the upcoming Annual General Meeting -- Chief Operating Officer, Dan Carestio, to succeed as President and CEO   GlobeNewswire Inc
Feb 2, 2021
05:06PM EST  STERIS plc (STE) announced a profit for its third quarter that increased from last year.   RTTNews
04:48PM EST  Recap: Steris Q3 Earnings   Benzinga
04:33PM EST  STERIS Q3 EPS $1.33 Vs $1.23 Last Year   RTTNews
04:30PM EST  Steris Q3 Adj. EPS $1.73 Beats $1.52 Estimate, Sales $808.90M Beat $792.98M Estimate   Benzinga
04:30PM EST  -- Third quarter revenue increases 4% as reported; 1% constant currency organic -- Third quarter earnings per diluted share increase to $1.33 on a U.S. GAAP basis and $1.73 on an adjusted basis -- Increased free cash flow driven by net income growth and working capital improvements   GlobeNewswire Inc
04:00AM EST  Earnings Scheduled For February 2, 2021   Benzinga
Feb 1, 2021
10:06AM EST  A Preview Of Steris's Earnings   Benzinga
Jan 19, 2021
04:30PM EST  STERIS to Host a Conference Call for Fiscal 2021 Third Quarter   GlobeNewswire Inc
Jan 13, 2021
07:30PM EST  SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of   GlobeNewswire Inc
Jan 12, 2021
05:06PM EST  SHAREHOLDER ALERT: WeissLaw LLP Investigates Cantel Medical Corp.   PR Newswire
01:30PM EST  ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Cantel Medical   PR Newswire
12:23PM EST  Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of Cantel Medical Corp. (NYSE: CMD) breached their fiduciary duties or violated the federal securities laws in connection with the companys acquisition by STERIS plc (NYSE: STE).   GlobeNewswire Inc
07:37AM EST  STERIS plc (STE) agreed to buy Cantel Medical Corp (CMD) in a cash and stock transaction valued at $84.66 per Cantel common share. It represents a total equity value of about $3.6 billion and a total enterprise value of about $4.6 billion, including Cantel's net debt and convertible notes.   RTTNews
07:24AM EST  STERIS Agrees To Acquire Cantel For $84.66/Shr   RTTNews
07:14AM EST  STERIS Announces Definitive Agreement To Acquire Cantel Medical In cash And Stock Transaction Valued At $84.66/Cantel Common Share   Benzinga
07:13AM EST  -- Complementary to STERISs product and service portfolio, focused on infection prevention -- Extends STERISs reach to Dental Customers -- $110 million in expected EBIT synergies by year four -- Accretive to adjusted earnings per diluted share in year one -- Conference call with STERIS and Cantel management today at 8:00 a.m. ET   GlobeNewswire Inc
Jan 7, 2021
05:14PM EST  STERIS To Participate in Upcoming Investor Conferences   GlobeNewswire Inc
Nov 18, 2020
04:33PM EST  STERIS Completes the acquisition of Key Surgical.   Benzinga
04:30PM EST  STERIS plc (NYSE: STE) (STERIS or the Company) today announced that is has completed the previously announced acquisition of Key Surgical, a portfolio company of Water Street Healthcare Partners, LLC.   GlobeNewswire Inc
Nov 2, 2020
05:48PM EST  Steris plc (STE) Monday reported second-quarter net income of $105.9 million or $1.23 per share, up from $94.8 million or $1.11 per share last year.   RTTNews
04:48PM EST  Steris Q2 EPS $1.23 Vs. $.11 Year Ago   RTTNews
04:42PM EST  Steris Q2 EPS $1.48 Beats $1.27 Estimate, Sales $756.10M Beat $722.87M Estimate   Benzinga
04:30PM EST  -- Second quarter revenue increases 3% as reported; 2% constant currency organic -- Second quarter earnings per diluted share increase to $1.23 on a U.S. GAAP basis and $1.48 on an adjusted basis -- Increased cash flow driven by net income growth and working capital improvements   GlobeNewswire Inc
07:55AM EST  Earnings Scheduled For November 2, 2020   Benzinga
Oct 20, 2020
07:00AM EDT  STERIS to Host a Conference Call for Fiscal 2021 Second Quarter   GlobeNewswire Inc
Oct 6, 2020
08:05AM EDT  Steris plc (STE) announced Tuesday that it has signed a definitive agreement to purchase Key Surgical, a portfolio company of Water Street Healthcare Partners, LLC, through a U.S. subsidiary for $850 million.   RTTNews
07:51AM EDT  Steris PLC To Buy Key Surgical For $850 Mln   RTTNews
07:18AM EDT  STERIS To Acquire Key Surgical For ~$850M   Benzinga
07:00AM EDT  -- Consumable product portfolio a natural extension for STERISs Customers in sterile processing departments, operating rooms and endoscopy -- Compelling financial benefits - accretive to top-line growth, margins and earnings -- Expected to close by December 31, 2020 -- Conference call with STERIS Management today at 10:00 a.m. ET   GlobeNewswire Inc
Sep 2, 2020
06:00AM EDT  Baird Initiates Coverage On Steris with Outperform Rating, Announces Price Target of $175   Benzinga
Aug 3, 2020
05:56PM EDT  STERIS plc (STE) Monday reported first-quarter net income of $88.2 million or $1.03 per share, up from $84.6 million or $0.99 per share last year.   RTTNews
04:46PM EDT  Steris Q1 EPS $1.03 Vs. $0.99 Year Ago   RTTNews
04:42PM EDT  Steris Q1 Adj. EPS $1.31 Beats $0.96 Estimate, Sales $668.90M Beat $635.98M Estimate   Benzinga
04:30PM EDT  First quarter revenue declines low-single digits due to reduction in deferrable procedures First quarter net income grows low-single digits driven by margin expansion Board increases dividend for 15th consecutive year   GlobeNewswire Inc
04:13AM EDT  Earnings Scheduled For August 3, 2020   Benzinga
Jul 31, 2020
11:15AM EDT  Earnings Preview: Steris   Benzinga
Jul 22, 2020
04:30PM EDT  STERIS to Host a Conference Call for Fiscal 2021 First Quarter   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC